Narayana Hrudayalaya Limited lists on the stock exchanges  

Narayana Hrudayalaya Limited (the “Company” or “Issuer”) listed on the stock exchanges after successfully completing an Initial Public Offer of 24,523,297 Equity Shares of Face Value of Rs. 10 Each (“Equity Shares”) for Cash at a Price of Rs. 250 Per Equity Share including  Share Premium of Rs. 240 per Equity Share (“Offer”) aggregating Rs. 6,130.82 million (“Offer Price”) through an Offer for Sale of 6,287,978 Equity Shares by Ashoka Investment Holdings Limited, 1,886,455 Equity Shares by Ambadevi Mauritius Holding Limited, 12,261,648 Equity Shares by JP Morgan Mauritius Holdings IV Limited (The “Investor Selling Shareholders”), 2,043,608 Equity Shares By Dr. Devi Prasad Shetty and 2,043,608 Equity Shares by Shakuntala Shetty (the “Promoter Selling Shareholders”) (together the “Selling Shareholders”) aggregating to Rs. 6,130.82 million (“Offer For Sale”). The Offer constitutes approximately 12% of the Company’s Post-Offer Paid-Up Share Capital.

Dr. Devi Shetty (Chairman and ED) and Dr. Ashutosh Raghuvanshi (MD and CEO) strike the gong in the presence of Left to Right - Mr. Venkatraghavan S (IDFC Capital Ltd.),  Mr. Balasubramanian V (BSE Ltd.),  Mr. Dharmesh Mehta (Axis Capital Ltd.), Mr. Ashwin Pai (Jefferies India Pvt. Ltd.), Mr. Kesavan Venugopalan (Group CFO), Ms. Kiran Mazumdar Shaw (CMD, Biocon Ltd. and Director, Narayana Hrudayalaya Ltd.), Mrs. Shakuntala Shetty and Mr. Viren Shetty (ED) during the listing ceremony of Narayana Hrudayalaya Ltd. in BSE

Dr. Devi Shetty (Chairman and ED) and Dr. Ashutosh Raghuvanshi (MD and CEO) strike the gong in the presence of Left to Right – Mr. Venkatraghavan S (IDFC Capital Ltd.),  Mr. Balasubramanian V (BSE Ltd.),  Mr. Dharmesh Mehta (Axis Capital Ltd.), Mr. Ashwin Pai (Jefferies India Pvt. Ltd.), Mr. Kesavan Venugopalan (Group CFO), Ms. Kiran Mazumdar Shaw (CMD, Biocon Ltd. and Director, Narayana Hrudayalaya Ltd.), Mrs. Shakuntala Shetty and Mr. Viren Shetty (ED) during the listing ceremony of Narayana Hrudayalaya Ltd. in BSE

Present on the occasion were Dr. Devi Shetty (Chairman and ED), Dr. Ashutosh Raghuvanshi (MD and CEO), Mr. Kesavan Venugopalan (Group CFO), Viren Shetty (ED), Mr. Dharmesh Mehta (Axis Capital Ltd.), Mr. Venkatraghavan S (IDFC), Ashwin Pai (Jefferies India Pvt. Ltd.) and Mr. Balasubramanian V (BSE Ltd.). Mrs. Shakuntala Shetty and Ms. Kiran Mazumdar Shaw (CMD, Biocon Ltd. and Director, Narayana Hrudayalaya Ltd.) also graced the occasion.

 

The equity shares of the Company opened at Rs. 291 and touched a high of Rs. 344 before closing the day at Rs. 336.70 on the BSE. The equity shares opened at Rs. 291, touched a high of Rs. 345.65 and closed at Rs. 340.80 on the NSE.

 

The Book Running Lead Managers (“BRLMs”) to the Offer are Axis Capital Limited, IDFC Securities Limited and Jefferies India Private Limited.

 

Founded in 2000 by Promoter, Dr. Devi Prasad Shetty, who has over 30 years of medical experience, including as a cardiac surgeon, the Company is one of the leading private healthcare service providers in India, operating a chain of multispecialty, tertiary and primary healthcare facilities. As of the date of the Red Herring Prospectus, it had a network of 23 hospitals (multispeciality and superspeciality healthcare facilities which provide tertiary care), 8 heart centres (superspeciality units which are set up in a third party hospital) and 24 primary care facilities (including clinics and information centres), across a total of 31 cities, towns and villages in India, with 5,442 operational beds and the potential to reach a capacity of up to 6,602 beds. In FY 2015, the facilities provided care to over 1.97 million patients. Headquartered in Bengaluru, it operates a national network of hospitals in India with a particularly strong presence in the southern state of Karnataka and eastern India, as well as an emerging presence in western and central India. As of September 30, 2015, it had 11,163 employees, which included 344 doctors, 5,587 nurses, 1,996 paramedical staff and 3,236 administrative personnel. Additionally, it had 487 students, which included 469 doctors, 14 paramedics and 4 administrative trainees. Further, it had 1,750 doctors on a consultancy basis (including visiting consultants) engaged in the system. For further details, please see the section titled “Our Business” on page 121 of the RHP.

 

Some of the investors include: Government Of Singapore, Monetary Authority Of Singapore, FIL Investments (Mauritius) Limited, Mirae Asset Asia Sector Leader Equity Fund, Reliance Capital Trustee Co. Ltd A/C Reliance Pharma Fund, Reliance Capital Trustee Co Ltd.A/C- Reliance Regular Savings Fund – Balanced Option, Birla Sunlife Trustee Company Private Limited A/C Birla Sun Life Advantage Fund, Birla Sunlife Trustee Company Private Limited A/C Birla Sunlife Midcap Fund, Hdfc Trustee Company Limited A/C Hdfc Growth Fund, Hdfc Trustee Company Ltd – Hdfc Core And Satellite Fund,    Icici Prudential Growth Fund Series – 6, Icici Prudential Growth Fund Series – 7, , Icici Prudential Growth Fund Series – 5, Dsp Blackrock Small And Mid Cap Fund, Uti – Master Equity Plan Unit Scheme, Uti – Pharma & Healthcare Fund, India Pharma Fund Unit Scheme Option A, Morgan Stanley Sicav Mauritius Limited, Chennai 2007, C/O Harvard Management Co. Inc, Morgan Stanley Mauritius Company Limited,  The Nomura Trust and Banking Co., Ltd As The Trustee Of Nomura India Stock Mother Fund, Sbi Pharma Fund, Sbi Magnum Midcap Fund, Sbi Equity Opportunities Fund – Series Iv,  Sbi Magnum Childrens Benefit Plan and Sbi Resurgent India Opportunities Scheme.

About the Author

Sachin Murdeshwar
Sachin Murdeshwar is a Sr.Journalist and Columnist in several Mainline Newspapers and Portals.He is an ardent traveller and likes to explore destinations to the core.